Finally, given the relative importance of deficient transcriptional initiation in FRDA, we propose that drugs that are designed to reactivate FXN transcriptional initiation would serve as a particularly efficient therapeutic strategy for FRDA. Here, FXN is linked to Friedreich ataxia.